& Talalay, P
This combination treatment alleviated multiple disorders in in vivo experiments, including cardiomyocyte hypertrophy, glucose and insulin tolerance, and Alzheimers disease, and is currently being tested in multiple clinical studies for different age-related diseases
In clinical studies the numbers are unusual for a sleep aid: DSIP increased total sleep time by about 59% in one trial, normalized sleep in people with chronic insomnia in another, and, most strikingly, several of those patients kept normal sleep for 3 to 7 months after their last injection
Scopolamine hydrobromide (S-1875) from Sigma-Aldrich was used to induce cognitive deficits in behavioral studies [2]
So, if youre curious about the science behind the ingredient, this is everything you need to know
If you mail it, send it to your local field office